Race and Ethnicity in Cancer Therapy: What Have We Learned?

被引：24
|
作者：
Grenade, C. [1 ,2 ]
Phelps, M. A. [1 ,3 ]
Villalona-Calero, M. A. [1 ,2 ]
机构：
[1] Ohio State Univ, Dept Internal Med, Div Med Oncol, Columbus, OH 43210 USA
[2] Ohio State Univ, Ctr Comprehens Canc, Columbus, OH 43210 USA
[3] Ohio State Univ, Coll Pharm, Div Pharmaceut, Columbus, OH 43210 USA
来源：
CLINICAL PHARMACOLOGY & THERAPEUTICS | 2014年 / 95卷 / 04期
关键词：
CELL LUNG-CANCER; BREAST-CANCER; AFRICAN-AMERICAN; RACIAL-DIFFERENCES; GENETIC POLYMORPHISMS; CYTOCHROME-P450; 3A4; COLORECTAL-CANCER; WHITE WOMEN; PHASE-II; SURVIVAL;
D O I：
10.1038/clpt.2014.5
中图分类号：
R9 [药学];
学科分类号：
1007 ;
摘要：
Racial and ethnic disparities in the pathogenesis of common malignancies and outcomes from treatment remain a major health concern. Factors attributed to these disparities include differences in lifestyle, environment, genetics, and tumor biology. As we strive to personalize cancer therapy, it will be imperative that we understand the relative contributions of each factor so that we may apply this knowledge in choosing the best treatment for each individual, regardless of his or her racial or ethnic heritage.
引用
收藏
页码：403 / 412
页数：10
相关论文
共 50 条
  • [1] Race and Diversity: What Have We Learned?
    Winders, Jamie
    Schein, Richard
    [J]. PROFESSIONAL GEOGRAPHER, 2014, 66 (02): : 221 - 229
  • [2] Thalidomide in lung cancer therapy—what have we learned?
    Martin Reck
    Ulrich Gatzemeier
    [J]. Nature Reviews Clinical Oncology, 2010, 7 : 134 - 135
  • [3] Sex and Race in Bladder Cancer: What We Have Learned and Future Directions
    Katz, Mark H.
    Steinberg, Gary D.
    [J]. CANCER, 2009, 115 (01) : 10 - 12
  • [4] Sodium, Blood Pressure, and Ethnicity: What Have We Learned?
    Gleiberman, Lillian
    [J]. AMERICAN JOURNAL OF HUMAN BIOLOGY, 2009, 21 (05) : 679 - 686
  • [5] Phage Therapy: What Have We Learned?
    Gorski, Andrzej
    Miedzybrodzki, Ryszard
    Lobocka, Malgorzata
    Glowacka-Rutkowska, Aleksandra
    Bednarek, Agnieszka
    Borysowski, Jan
    Jonczyk-Matysiak, Ewa
    Lusiak-Szelachowska, Marzanna
    Weber-Dabrowska, Beata
    Baginska, Natalia
    Letkiewicz, Slawomir
    Dabrowska, Krystyna
    Scheres, Jacques
    [J]. VIRUSES-BASEL, 2018, 10 (06):
  • [6] Targeted Therapy in Advanced Bladder Cancer What Have We Learned?
    Jordan, Emmet J.
    Iyer, Gopa
    [J]. UROLOGIC CLINICS OF NORTH AMERICA, 2015, 42 (02) : 253 - +
  • [7] Cancer Chemoprevention: What Have we Learned?
    Yang C.S.
    Wang H.
    Dan V.
    Filippo S.S.
    [J]. Current Pharmacology Reports, 2017, 3 (6) : 409 - 422
  • [8] Cancer clusters: what have we learned?
    Stewart, B. W.
    [J]. INTERNAL MEDICINE JOURNAL, 2013, 43 (01) : 5 - 6
  • [9] Lymphopenia in Esophageal Cancer: What Have We Learned?
    Wang, Jia-Lin
    Ma, Rong
    Kong, Wei
    Zhao, Ren
    Wang, Yan-Yang
    [J]. FRONTIERS IN ONCOLOGY, 2021, 11
  • [10] DNA Sequencing of Cancer: What Have We Learned?
    Chmielecki, Juliann
    Meyerson, Matthew
    [J]. ANNUAL REVIEW OF MEDICINE, VOL 65, 2014, 65 : 63 - 79
12345